ASC47
Asset
Thyroid hormone receptor beta agonist under evaluation for metabolic disorders and weight management
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 363
- Trials
- 1
- Developer
Indications
1Chronic weight management
Phase 1, Completed, NCT06972992, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials363
- Evidence for its targets2
- Competitors1
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.